FAM168A-RAB6A Fusion FISH Probe
The FAM168A-RAB6A Fusion FISH Probe is used to confirm a fusion of the FAM168A and RAB6A genes. The fusion of the FAM168A and RAB6A genes has been associated with Breast Invasive Carcinoma, Uterine Corpus Endometrial Carcinoma, and Lung Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FAM168A-RAB6A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FAM168A-RAB6A-20-AQAQ | 20 (40 μL) | 200 μL |
|
RAB6A Gene Summary
This gene encodes a member of the RAB family, which belongs to the small GTPase superfamily. GTPases of the RAB family bind to various effectors to regulate the targeting and fusion of transport carriers to acceptor compartments. This protein is located at the Golgi apparatus, which regulates trafficking in both a retrograde (from early endosomes and Golgi to the endoplasmic reticulum) and an anterograde (from the Golgi to the plasma membrane) directions. Myosin II is an effector of this protein in these processes. This protein is also involved in assembly of human cytomegalovirus (HCMV) by interacting with the cellular protein Bicaudal D1, which interacts with the HCMV virion tegument protein, pp150. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2011]
Gene Name: RAB6A, Member RAS Oncogene Family
Chromosome: CHR11: 73386682 -73472201
Locus: 11q13.4
FAM168A Gene Summary
The Family With Sequence Similarity 168 Member A (FAM168A) gene is located on chr11 :73117027-73309228 at 11q13.4.
Gene Name: Family With Sequence Similarity 168 Member A
Chromosome: CHR11: 73117027 -73309228
Locus: 11q13.4
Gene Diseases
The FAM168A RAB6A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
| Uterine Corpus Endometrial Carcinoma |
| Lung Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|